News & Media
Press Releases
Amolyt Pharma to Present New Phase 1 Data on AZP-3601, its Parathyroid Hormone Analog for Hypoparathyroidism, and Preclinical Data on AZP-3404 at Upcoming Scientific Conferences
Download a PDF copy of this press release: EN FR New data from all cohorts of Phase 1 Single Ascending Dose clinical trial accepted for …
Amolyt Pharma Presents First Clinical Data for AZP-3601, its Parathyroid Hormone Analog for Hypoparathyroidism, at the Endocrine Society’s Virtual Annual Meeting (ENDO 2021)
Download a PDF copy of this press release: EN FR Data from first 4 cohorts of the single ascending dose (SAD) study show that AZP-3601 …
Amolyt Pharma to Present Preliminary Phase 1 Data on AZP-3601 for Hypoparathyroidism and Additional Preclinical Data on AZP-3404 at ENDO 2021
Download a PDF copy of this press release: EN FR Four abstracts accepted as poster presentations for the Endocrine Society’s Annual Meeting LYON, France, and …
Presentations
- All PRESENTATIONS
- AZP-3404
- AZP-3601
- Uncategorized
- All PRESENTATIONS
- AZP-3404
- AZP-3601
- Uncategorized
Upcoming events
90th Annual Meeting of the American Thyroid Association®
Date: September 29 – October 3, 2021 (Virtual)
Hypopara Patient Association Meeting
Date: October 2021
ASBMR 2021 Annual Meeting
Date: October 1-4, 2021 (Toronto)
37eme Congrès de la Société Française d’Endocrinologie (SFE)
Date: October 13-16, 2021 (Le Havre)
AMCP Nexus 2021
Date: October 19-22, 2021 (Denver, CO)
American Society of Nephrology (ASN) Kidney Week 2021
Date: November 2-7, 2021 (San Diego, CA)
Acromegaly Awareness Day
Date: November 1, 2021
Social Updates
TWITTER